Lynne Hohlfeld

Lynne Hohlfeld is chief financial officer and senior vice president of corporate development of Asuragen, a molecular diagnostics company changing the way patients are treated in genetics and oncology that is leading the burgeoning life sciences community in Austin, Texas. Lynne has extensive experience in financial management of life science companies having held leadership roles at Opexa Therapeutics (Nasdaq: OPXA), Denota Ventures, Bacterial Barcodes, Inc., Spectral Genomics and LifeCell Corporation. Her career also includes positions at Dixie Chemical Company, Price WaterhouseCoopers, McKenna & Company and Arthur Andersen. Lynne received her B.B.A. in Accounting from the University of Wisconsin—Madison.

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]